Research Opportunities for Neurology and Neurosurgery Residents and Fellows
The Department of Neurobiology and Anatomy consists of roughly 15 active research laboratories, all of which study various aspects of neuroscience relevant to human diseases, developmental disorders, and recovery after injury. Ongoing investigations in the department involve studies on whole animals as well as studies on various culture systems of neurons and glial cells. We are funded by several grants from the National Institutes of Health, including a “program project grant” to support our spinal cord research, as well as two training grants to assist in funding our postdoctoral fellows. The environment is vibrant, consisting of a great deal of interaction among the laboratories, several journal clubs, and a weekly seminar series. The department is well equipped with shared confocal microscopy as well as biochemistry facilities. There are also modern facilities for surgical procedures, and the individual laboratories are well equipped with several different kinds of microscopes and equipment for molecular biology. Neurology residents will be able to perform basic research that is highly relevant to the clinical setting. Opportunities include the following general areas of interest, but are constantly expanding as the department grows.
Diseases Related to the Neuronal Cytoskeleton
Disruption of cellular function underlies disease states. It is therefore
of great importance to understand both the cell biology of healthy cells
and how cellular processes are disrupted in diseased individuals. Several
faculty members in our department have strong interests in the cell biology
of neurons vis-a-vis their normal function and in response to injury. There
is a strong focus on the use of modern biochemical, molecular biology and
imaging methods. The laboratories of Drs. Peter
Baas, Gianluca
Gallo, and
Douglas Baird focus on understanding microtubules and actin filaments,
which are key components of the neuronal cytoskeleton. Dr.
Baas has interests
in understanding the roles of microtubule-related proteins (such as molecular
motors and severing proteins) in the development of axons and dendrites,
and in the regeneration of injured axons. Dr.
Gallo’s laboratory is investigating the mechanism of axonal retraction. Axonal retraction
is important to the establishment of correct connectivity patterns between
neurons during development by removing inappropriate connections. However,
axons also retract in the adult nervous system in response to injury. Retraction
of axons following injury results in the loss of connectivity between neurons.
Dr. Gallo’s laboratory is investigating the role of actin filaments
and myosin motor proteins in driving axon retraction. The results of these
studies are predicted to delineate potential molecular targets for therapies
aimed at minimizing axonal retraction following injury. The laboratories
of Dr. Baas and Dr.
Gallo are also researching the cytoskeletal basis of
axonal extension with the aim of determining methods to improve regeneration
in the injured nervous system. Dr.
Baird is interested in the behaviors
of microtubules and actin filaments within the growth cones of axons that
are extending during development and recovery after injury. In conjunction
with Dr. Itzhak
Fischer, a pioneer in the studies of tau (a microtubule-associated
protein that goes awry during Alzheimer’s disease), Dr.
Baas hopes
to develop new strategies for studying the cell biological deficits that
impair the brains of these patients. Drs. Baas, Gallo, and Baird actively
collaborate and provide a vibrant environment for studying the cell biology
of the neuronal cytoskeleton in healthy and injured neurons.
Spinal Cord Injury and Regeneration
For over twenty years, a group of faculty members in our department have joined
together to study ways of promoting recovery after spinal injury. They have
taken advantage of recent advances in stem cell biology, gene therapy, physiology
of locomotion, bioengineering and pharmacological interventions to open new
avenues for more effective treatment of this previously intractable condition.
The spinal cord research center is engaged in an innovative and multidisciplinary
program for studying the pathophysiology of spinal cord injury and the use of
various therapeutic strategies that include transplantation, drug therapy, physical
rehabilitation, functional electrical stimulation, biomaterials and robotics.
The goal and mission are "to bridge the gap between the discovery phase
and clinical application by optimizing promising research strategies and developing
effective and responsible protocols to treat patients whose function has been
limited by spinal cord injury." Most of the projects within the spinal
cord research center already include clinicians at different levels and can
therefore provide opportunities for Neurology residents that are interested
in research. Dr.
Marion Murray together with Dr.
Alan Tessler use genetically modified cells, which secrete trophic factors
to increases neuronal survival, encourage regeneration leading to recovery of
motor function. The motor recovery is further enhanced by administration of
agents that mimic transmitters, such as serotonin, that normally act as modulators
of motor function. Dr.
Itzhak Fischer is working on development of cellular and molecular strategies
for cellular replacement and repair of spinal cord injury. His research projects
are focused on the study and transplantation of neural stem cells and bone marrow
stromal cells into the CNS. The work includes collaborations with clinicians
at the Department of Neuroengineering, biomaterial engineers at the Drexel University
and two biotechnology companies Neuronyx and Osiris Therapeutics. Drs. Simon
Giszter and Michel
Lemay are interested in the biomechanics of spinal cord recovery of function
and utilizing spinal circuits responsible for movements in neural prosthesis
applications. They use computer-based modeling of limb biomechanics, kinematic
analysis of movement behavior, and in vivo stimulation and recording of force,
motion and muscular activation in pre-clinical models.
Peripheral neuropathy
Our department also has strong interests in diseases that afflict the peripheral
nervous system, both developmentally and later in life. Several research
projects are currently underway and have particular relevance to peripheral
pathopathies such as ALS and muscular dystrophies. Dr.
Young-Jin Son studies
how nerve-muscle synapses are properly formed and maintained during development
and adulthood. Particular emphasis is given to novel muscular/glial components
and their signal transduction pathways, which Dr.
Son believes are essential
for synaptic maintenance and potentially could be key to developing new
strategies for clinical interventions to reverse degeneration of motoneurons
or muscle fibers. Dr.
Son is also interested in understanding how nerve-muscle
synapses regenerate following nerve or muscle damages. This project focuses
on the role of Schwann cells as an active trigger of the repair, a novel
concept being developed in his laboratory. The goal is to understand how
glial cells initiate and coordinate PNS repair, with the hope that the
work will lead to novel insights into synaptic roles of glial cells, pathogenesis
of neural and muscular disorders, and therapeutic strategy to repair synapses
elsewhere in our nervous system. Dr.
Baas is currently studying a novel
class of new anti-cancer drugs which, unlike traditional cancer drugs such
as the taxanes, do not appear to produce severe peripheral neuropathies
in patients. However, this needs to be thoroughly evaluated in animal models.
Dr. Gallo is studying the long axons produced by peripheral sensory neurons,
with the aim of understanding how they regenerate after severing. Various
molecular and cellular techniques are being used by these laboratories,
which include contemporary tools and techniques such as tissue-specific
inducible mouse transgenics.
Other opportunities
In addition to the major foci described above, the department has other areas
of strength that are beginning to prosper. Drs. Baas and Baird are very
interested in the issue of neuronal migration, which goes awry in developmental
neurological diseases such as lissencephaly and autism. Dr.
Timothy Cunningham studies potential mechanisms of neuroprotection
that are highly relevant to the clinical setting. Dr.
Manuel Castro-Alamancos is performing state-of-the-art
neurophysiological analyses involving recordings from single cells in living
animals. This work enables him, and colleagues including Drs. Barry
Waterhouse and Michelle
Page, to study issues relevant to epilepsy in
animal models. Dr. Ramesh Raghupathi has recently joined our department,
and leads a strong program covering all aspects of traumatic head injury.
We are also eager for Neurology residents to bring their own interests
to our laboratories, to even further expand our research into new areas
of clinical relevance.

